Zurueck zur Suche

Reporte zur Charge U004367

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

4Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
VT 1 TX 1 CO 1 NV 1

VAERS 2123625

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge U004367

mild
Staat
VT
Alter
21,0
Geschlecht
M
Eingang
18.02.2022
Impfdatum
16.02.2022
Beginn
16.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dizziness Headache

Symptomtext

The patient developed light-headedness and dizziness along with headache the evening after vaccines were given

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
NA
Vorgeschichte
Diabetes, Depression
Andere Medikamente
Novolog
Allergien
Lactose, dust, poison ivy
Vorherige Impfungen
-

VAERS 2311162

MERCK & CO. INC. · HEP A (VAQTA) · Charge U004367

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
07.06.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE reported; Patient was administered expired VAQTA; This spontaneous report has been received from a registered nurse regarding a patient of unknown age and gender. The patient's medical history, current conditions, previous drug reactions or allergies, and concomitant medications were not reported. On 03-MAY-2022, the patient was administered an expired hepatitis A vaccine, inactivated (VAQTA) as prophylaxis (lot number U004367, which was determined to be valid for syringe formulation, with an expiration date of 11-APR-2022) (dose, dose number, vaccination scheme, route and anatomical location of administration were not reported) (expired product administered). No additional adverse event was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2266746

MERCK & CO. INC. · HEP A (VAQTA) · Charge u004367

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
07.05.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional adverse events reported; administration of expired VAQTA; This spontaneous report was received from medical assistant and concerns a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 19-APR-2022, the patient was vaccinated with an expired dose of Hepatitis A Vaccine, Inactivated (VAQTA) in dose of 1 ml, lot number: U004367 was confirmed to be valid, expiration date: 11-APR-2022 (route and site of administration were not reported) for prophylaxis (expired product administered). No additional adverse event was reported (no adverse event).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2251446

MERCK & CO. INC. · HEP A (VAQTA) · Charge U004367

gering
Staat
NV
Alter
-
Geschlecht
U
Eingang
26.04.2022
Impfdatum
18.04.2022
Beginn
18.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional adverse events reported.; Medical Assistant reporting the administration of expired VAQTA and inquiring viability of the administration of expired dose.; This spontaneous report was received from a medical assistant, referring to a patient of unknown age and gender. Information regarding the patient's concurrent conditions, concomitant medications pertinent medical history or drug reactions/allergies was not provided. On 18-APR-2022, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, dose of 1 mL, lot number: U004367 was confirmed to be valid, expiration date: 11-APR-2022 (route of administration and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse events reported (no adverse event). No product quality complaints reported. No further details were provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-